EP 1246923 A2 20021009 - DNA MODIFICATION PROTEINS
Title (en)
DNA MODIFICATION PROTEINS
Title (de)
DNS MODIFIKATIONSPROTEINE
Title (fr)
PROTEINES DE MODIFICATION D'ADN
Publication
Application
Priority
- US 0100870 W 20010110
- US 17617800 P 20000113
Abstract (en)
[origin: WO0151642A2] The invention provides human DNA modification proteins (DNAMP) and polynucleotides which identify and encode DNAMP. The invention also provides expression vectors, host cells, antibodies, agonists, and antogonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of DNAMP.
IPC 1-7
C12N 15/54; C12N 15/12; C12N 9/12; C07K 14/47; C07K 16/18; C07K 16/40; C12Q 1/68; G01N 33/50; G01N 33/68; A01K 67/027
IPC 8 full level
G01N 33/50 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61P 15/08 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C07K 16/40 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 9/02 (2006.01); C12N 9/10 (2006.01); C12N 9/12 (2006.01); C12N 9/90 (2006.01); C12N 15/09 (2006.01); C12N 15/54 (2006.01); C12P 21/02 (2006.01); C12Q 1/26 (2006.01); C12Q 1/48 (2006.01); C12Q 1/533 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01)
CPC (source: EP)
A61P 15/08 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C12N 9/1252 (2013.01); A01K 2217/05 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 0151642A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0151642 A2 20010719; WO 0151642 A3 20020328; AU 2783001 A 20010724; CA 2406722 A1 20010719; EP 1246923 A2 20021009; JP 2004500817 A 20040115
DOCDB simple family (application)
US 0100870 W 20010110; AU 2783001 A 20010110; CA 2406722 A 20010110; EP 01901980 A 20010110; JP 2001551216 A 20010110